Ropivacaine Inhibits the Growth, Migration and Invasion of Gastric Cancer Through Attenuation of WEE1 and PI3K/AKT Signaling via miR-520a-3p

BACKGROUND: Metastasis remains one of the greatest challenges involved in treating gastric cancer (GC). Ropivacaine (Rop) is not only a well-documented local anesthetic medicament but also has been reported to exert an antitumor role in cancer development. This study explored the effects of ropivaca...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Nianliang, Xing, Xiangji, Gu, Fengcai, Zhou, Gang, Liu, Xianglan, Li, Baoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294106/
https://www.ncbi.nlm.nih.gov/pubmed/32606749
http://dx.doi.org/10.2147/OTT.S244550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294106/
https://www.ncbi.nlm.nih.gov/pubmed/32606749
http://dx.doi.org/10.2147/OTT.S244550

Ejemplares similares